BC Week In Review | Jun 28, 2010
Company News

CGI, Gilead deal

Gilead will acquire CGI (formerly Cellular Genomics Inc. ) for up to $120 million in cash. An undisclosed majority of the payment will be paid up front, with the remainder to be paid upon clinical milestones....
BC Extra | Jun 25, 2010
Company News

Gilead to acquire CGI

Gilead Sciences Inc. (NASDAQ:GILD) will acquire CGI Pharmaceuticals Inc. (Branford, Conn.) for up to $120 million in cash. An undisclosed majority of the $120 million will be paid up front, with the remainder to be...
BC Week In Review | Oct 9, 2006
Company News

CGI, Genentech deal

CGI granted DNA exclusive worldwide rights to discover, develop and commercialize small molecule therapeutics against an undisclosed CGI target for cancer and autoimmune indications. CGI will retain rights in the EU. DNA will pay CGI...
BC Extra | Oct 4, 2006
Top Story

Genentech in-licenses CGI target

CGI (Branford, Conn.) granted DNA exclusive worldwide rights to discover, develop and commercialize small molecule therapeutics against an undisclosed CGI target for cancer and autoimmune indications. CGI will retain rights in the EU. DNA will...
BioCentury | May 2, 2005
Finance

MPM's portfolio

MPM's portfolio Company Business Region Last MPM round (A) Date Raised MPM directors Acorda Neurology U.S. ND 5/9/03 $55.3 Michael Steinmetz Affymax Cancer; Hematology U.S. Series C 6/23/03 $40.0 Nicholas Galakatos Amphora Chemistry; Genomics U.S....
BC Week In Review | Mar 14, 2005
Company News

Cellular Genomics management update

Cellular Genomics Inc. , Branford, Conn.   Business: Genomics, Functional genomics, Proteomics   Hired: Peter Fuller as CBO, formerly SVP of business development at Molecular Staging Inc.  ...
BC Week In Review | Feb 21, 2005
Company News

Cellular Genomics, Serono SA deal

Cellular Genomics received an undisclosed milestone from SEO under a 2002 kinase discovery deal. The milestone was triggered by Cellular Genomics developing in vivo models for kinase discovery. Cellular Genomics Inc. , Branford, Conn.   Serono...
BC Week In Review | Oct 11, 2004
Company News

Cellular Genomics management update

Cellular Genomics Inc. , Branford, Conn.   Business: Genomics   Hired: Udo Klein as SVP of drug development, formerly SVP of R&D at EntreMed Inc.  ...
BioCentury | Sep 13, 2004
Strategy

Serono's discovery network

Serono's discovery network Company Activity Cellular Genomics Provides chemical genetics for kinase targets. Graffinity Applies its Rapid Affinity Instructed Structure Evolution (RAISE) technology and drug-fragment chemical microarrays to identify small molecules for SEO (see Strategy,...
BC Week In Review | Jun 21, 2004
Company News

Cellular Genomics board of directors update

Cellular Genomics Inc. , Branford, Conn.   Business: Genomics   Appointed: Gordon Binder, managing director of Coastview Capital  ...
Items per page:
1 - 10 of 44
BC Week In Review | Jun 28, 2010
Company News

CGI, Gilead deal

Gilead will acquire CGI (formerly Cellular Genomics Inc. ) for up to $120 million in cash. An undisclosed majority of the payment will be paid up front, with the remainder to be paid upon clinical milestones....
BC Extra | Jun 25, 2010
Company News

Gilead to acquire CGI

Gilead Sciences Inc. (NASDAQ:GILD) will acquire CGI Pharmaceuticals Inc. (Branford, Conn.) for up to $120 million in cash. An undisclosed majority of the $120 million will be paid up front, with the remainder to be...
BC Week In Review | Oct 9, 2006
Company News

CGI, Genentech deal

CGI granted DNA exclusive worldwide rights to discover, develop and commercialize small molecule therapeutics against an undisclosed CGI target for cancer and autoimmune indications. CGI will retain rights in the EU. DNA will pay CGI...
BC Extra | Oct 4, 2006
Top Story

Genentech in-licenses CGI target

CGI (Branford, Conn.) granted DNA exclusive worldwide rights to discover, develop and commercialize small molecule therapeutics against an undisclosed CGI target for cancer and autoimmune indications. CGI will retain rights in the EU. DNA will...
BioCentury | May 2, 2005
Finance

MPM's portfolio

MPM's portfolio Company Business Region Last MPM round (A) Date Raised MPM directors Acorda Neurology U.S. ND 5/9/03 $55.3 Michael Steinmetz Affymax Cancer; Hematology U.S. Series C 6/23/03 $40.0 Nicholas Galakatos Amphora Chemistry; Genomics U.S....
BC Week In Review | Mar 14, 2005
Company News

Cellular Genomics management update

Cellular Genomics Inc. , Branford, Conn.   Business: Genomics, Functional genomics, Proteomics   Hired: Peter Fuller as CBO, formerly SVP of business development at Molecular Staging Inc.  ...
BC Week In Review | Feb 21, 2005
Company News

Cellular Genomics, Serono SA deal

Cellular Genomics received an undisclosed milestone from SEO under a 2002 kinase discovery deal. The milestone was triggered by Cellular Genomics developing in vivo models for kinase discovery. Cellular Genomics Inc. , Branford, Conn.   Serono...
BC Week In Review | Oct 11, 2004
Company News

Cellular Genomics management update

Cellular Genomics Inc. , Branford, Conn.   Business: Genomics   Hired: Udo Klein as SVP of drug development, formerly SVP of R&D at EntreMed Inc.  ...
BioCentury | Sep 13, 2004
Strategy

Serono's discovery network

Serono's discovery network Company Activity Cellular Genomics Provides chemical genetics for kinase targets. Graffinity Applies its Rapid Affinity Instructed Structure Evolution (RAISE) technology and drug-fragment chemical microarrays to identify small molecules for SEO (see Strategy,...
BC Week In Review | Jun 21, 2004
Company News

Cellular Genomics board of directors update

Cellular Genomics Inc. , Branford, Conn.   Business: Genomics   Appointed: Gordon Binder, managing director of Coastview Capital  ...
Items per page:
1 - 10 of 44